Intuitive Surgical Inc (ISRG) — Q3 2025 Revenue, Income Growth and Profitability Ratios Compared to Peers
Quarterly Revenue & Net Income Growth — Intuitive Surgical Inc vs Peers
Table 1: Revenue and net income growth for the 3 Months period, most recent quarter Q3 2025
| COMPANY NAME TICKER |
Period | REVENUE (Y/Y %) |
REVENUE (Q/Q %) |
INCOME (Y/Y %) |
INCOME (Q/Q %) |
|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG |
Q3 2025 | 22.9% | 2.6% | 24.3% | 6.8% |
| Johnson and Johnson JNJ |
Q3 2025 | 6.8% | 1.1% | 91.2% | -7.0% |
| Thermo Fisher Scientific Inc TMO |
Q3 2025 | 4.9% | 2.5% | -0.5% | 0.2% |
| Medtronic Plc MDT |
Q3 2025 | 6.6% | 4.5% | 8.1% | 31.9% |
| Stryker Corp SYK |
Q3 2025 | 10.3% | 0.6% | 3.0% | -2.8% |
| Danaher Corporation DHR |
Q3 2025 | 4.4% | 2.0% | 11.0% | 63.6% |
| Boston Scientific Corporation BSX |
Q3 2025 | 20.3% | 0.1% | 61.3% | -5.0% |
| Roper Technologies Inc ROP |
Q3 2025 | 14.4% | 3.8% | 8.3% | 5.3% |
| Zimmer Biomet Holdings Inc ZBH |
Q3 2025 | 9.7% | -3.7% | -7.3% | 50.7% |
| Edwards Lifesciences Corporation EW |
Q3 2025 | 14.7% | 1.4% | -90.5% | -12.4% |
| Osi Systems inc OSIS |
Q3 2025 | 11.8% | -24.0% | 14.6% | -61.0% |
| Conmed Corporation CNMD |
Q3 2025 | 6.7% | -1.3% | -94.2% | -86.7% |
| Blackline Inc BL |
Q2 2025 | 7.0% | 3.3% | -90.1% | 40.1% |
| Bioventus Inc BVS |
Q3 2025 | -8.2% | 12.3% | -112.5% | -220.6% |
| Zimvie Inc ZIMV |
Q2 2025 | -0.1% | 4.2% | -1.7% | 168.3% |
| Procept Biorobotics Corporation PRCT |
Q3 2025 | 43.3% | 5.4% | 2.1% | 9.4% |
| Edap Tms Sa EDAP |
Q4 2024 | 6.1% | 6.1% | -10.2% | -10.2% |
| Pulmonx Corporation LUNG |
Q3 2025 | 5.1% | -9.3% | -1.3% | -8.0% |
| Tela Bio Inc TELA |
Q3 2025 | 5.9% | 4.5% | -17.1% | -13.3% |
| Lensar Inc LNSR |
Q3 2025 | 5.7% | 2.7% | 147.2% | 110.5% |
| Ss Innovations International Inc AVMR |
Q3 2025 | 252.7% | 28.3% | 32.9% | 1,348.4% |
| Utah Medical Products Inc UTMD |
Q3 2025 | -2.0% | 0.1% | -26.2% | -13.7% |
| Clearpoint Neuro Inc CLPT |
Q3 2025 | 9.1% | -3.8% | 18.4% | 0.9% |
| Lifeward Ltd LFWD |
Q3 2025 | 1.1% | 8.2% | 2.8% | -51.7% |
| Profound Medical Corp PROF |
Q3 2025 | -26.5% | 139.2% | -72.1% | -49.2% |
| Icad Inc ICAD |
Q1 2025 | -1.6% | 9.9% | -31.8% | -2.5% |
| Hyperfine Inc HYPR |
Q3 2025 | -2.1% | 22.3% | 6.7% | 19.5% |
| Milestone Scientific Inc MLSS |
Q3 2025 | -6.1% | 1.6% | -21.0% | -22.2% |
| Allurion Technologies Inc ALUR |
Q3 2025 | -54.9% | -31.8% | 32.0% | 27.3% |
| Asensus Surgical Inc ASXC |
Q2 2024 | 58.6% | 45.1% | 15.9% | 14.5% |
| Avinger Inc AVGR |
Q3 2024 | 2.7% | 3.5% | 98.8% | -11.9% |
| Bionik Laboratories Corp BNKL |
Q1 2023 | 158.2% | -12.9% | -618.1% | 26.0% |
| Reshape Lifesciences Inc RSLS |
Q3 2025 | -98.5% | -97.2% | 443.7% | 226.8% |
| Autonomix Medical Inc AMIX |
Q3 2025 | - | - | 165.4% | 123.3% |
| Vicarious Surgical Inc RBOT |
Q3 2025 | - | - | -35.3% | -16.3% |
| Adagio Medical Holdings inc ADGM |
Q3 2025 | -100.0% | - | -6.0% | 156.4% |
| Ir med Inc IRME |
Q2 2025 | - | - | 91.5% | -9.3% |
| SUBTOTAL | Q3 2025 | 16.7% | 9.8% | 3.0% | 4.4% |
This table compares Intuitive Surgical Inc ’s quarterly revenue and net income growth to that of its corporate peers. It highlights how each company’s top-line and bottom-line performance changed during the most recent 3-month period Q3 2025. The first row displays Intuitive Surgical Inc ’s growth rates, followed by the performance of its peer group, allowing for a clear comparison of short-term momentum and operational trends across corporate peers. For more detailed financial information, analysis, and historical trends, simply click on any company name within the table to open its full comparison.
Growth rates are calculated using Y/Y and
Q/Q comparisons based on reported totals from the most recent
quarterly and annual filings submitted to the U.S. Securities and Exchange Commission (SEC).
All data is derived from CSIMarket.com’s
proprietary fundamentals database, which aggregates, standardizes, and normalizes structured XBRL filings.
Figures may be updated or restated following SEC amendments or revised issuer disclosures.
These tables include both corporate and publicly traded peers, allowing for a uniform
comparison of financial trends and short-term growth dynamics within the group.
For detailed company revenue growth rates, see
Revenue Growth Details, and for net income growth, see
Net Income Growth Details.
CSIMarket data powering this analysis is available across multiple delivery channels:
• Data Downloads (CSV / Excel)
• API & Programmatic Data Access
• Enterprise Data Licensing
• AI Training & Model Development License
• Marketplace Distribution Options
All CSIMarket datasets are designed for analytical workflows, financial modeling, academic research,
and AI/ML applications requiring normalized, reliable, and longitudinal financial time series.
Intuitive Surgical Inc 's Return on Assets, Investments and Equity, Receivables and Inventory Turnover vs Peers Comparison
Table 2: ROA, ROI And ROE based on Net Income for the 12 Months ended in Q3 2025, Inventory turnover based on costs of sale
| COMPANY NAME TICKER |
ROA (TTM %) |
ROI (TTM %) |
ROE (TTM %) |
RECEIVABLES TURNOVER (Ratio) |
INVENTORY TURNOVER (Ratio) |
|---|---|---|---|---|---|
|
Intuitive Surgical Inc ISRG |
14.28% | 15.55% | 16.09% | 7.73 | 1.99 |
| Johnson and Johnson JNJ |
13.22% | 17.94% | 32.69% | 5.56 | 2.23 |
| Thermo Fisher Scientific Inc TMO |
6.56% | 8.06% | 13.12% | 5.12 | 2.42 |
| Medtronic Plc MDT |
5.27% | 6.00% | 9.84% | 5.50 | 2.07 |
| Stryker Corp SYK |
8.00% | 9.51% | 17.48% | 7.42 | 2.09 |
| Danaher Corporation DHR |
4.19% | 5.05% | 6.76% | 6.12 | 3.53 |
| Smith and Nephew Plc SNN |
2.63% | 10.52% | N/A | 2.32 | N/A |
| Boston Scientific Corporation BSX |
6.80% | 8.30% | 12.28% | 7.10 | 2.12 |
| Roper Technologies Inc ROP |
4.81% | 5.40% | 8.08% | 7.68 | 18.46 |
| Zimmer Biomet Holdings Inc ZBH |
3.59% | 4.03% | 6.44% | 5.15 | 0.97 |
| Edwards Lifesciences Corporation EW |
10.31% | 11.56% | 13.27% | 6.84 | 1.05 |
| Osi Systems inc OSIS |
6.96% | 10.23% | 16.91% | 2.30 | 2.67 |
| Conmed Corporation CNMD |
2.77% | 3.17% | 6.49% | 5.87 | 1.73 |
| Blackline Inc BL |
5.11% | 7.22% | 22.03% | 4.23 | N/A |
| Bioventus Inc BVS |
-0.70% | N/A | N/A | 4.46 | 1.94 |
| Zimvie Inc ZIMV |
-2.56% | N/A | N/A | 5.99 | N/A |
| Procept Biorobotics Corporation PRCT |
-16.28% | N/A | N/A | 3.66 | 1.70 |
| Edap Tms Sa EDAP |
-22.10% | N/A | N/A | 3.16 | 2.03 |
| Pulmonx Corporation LUNG |
-37.90% | N/A | N/A | 6.42 | 1.45 |
| Tela Bio Inc TELA |
-53.25% | N/A | N/A | 6.93 | 1.87 |
| Jin Medical International Ltd ZJYL |
8.75% | 12.00% | 12.00% | 3.82 | 2.58 |
| Lensar Inc LNSR |
-73.64% | N/A | N/A | 9.38 | 1.91 |
| Ss Innovations International Inc AVMR |
-26.58% | N/A | N/A | 5.38 | 1.16 |
| Utah Medical Products Inc UTMD |
8.92% | 9.17% | 9.25% | 9.24 | 1.77 |
| Clearpoint Neuro Inc CLPT |
-48.09% | N/A | N/A | 8.26 | 2.02 |
| Lifeward Ltd LFWD |
-109.28% | N/A | N/A | 4.23 | 2.17 |
| Profound Medical Corp PROF |
111.56% | 126.99% | 136.27% | 3.19 | 0.87 |
| Icad Inc ICAD |
-13.66% | N/A | N/A | 3.01 | 3.26 |
| Hyperfine Inc HYPR |
-80.50% | N/A | N/A | 1.51 | 1.13 |
| Milestone Scientific Inc MLSS |
-75.29% | N/A | N/A | 14.65 | 0.58 |
| Allurion Technologies Inc ALUR |
-117.10% | N/A | N/A | 2.75 | 1.94 |
| Asensus Surgical Inc ASXC |
-152.75% | N/A | N/A | 6.40 | 1.38 |
| Avinger Inc AVGR |
-128.65% | N/A | N/A | 5.56 | 0.97 |
| Bionik Laboratories Corp BNKL |
-132.95% | N/A | N/A | 4.84 | 0.66 |
| Reshape Lifesciences Inc RSLS |
-168.37% | N/A | N/A | 4.16 | 0.59 |
| Autonomix Medical Inc AMIX |
-172.59% | N/A | N/A | N/A | N/A |
| Vicarious Surgical Inc RBOT |
-100.39% | N/A | N/A | N/A | N/A |
| Adagio Medical Holdings inc ADGM |
-119.32% | N/A | N/A | N/A | 0.81 |
| Ir med Inc IRME |
867.96% | N/A | N/A | N/A | N/A |
| SUBTOTAL | 0.08% | 0.10% | 0.16% | 5.56 | 2.29 |
This table compares Intuitive Surgical Inc ’s profitability and efficiency ratios to those of its corporate peers. It shows how effectively each company generated returns on assets, investments, and equity over the 12-month period ending in Q3 2025, as well as how efficiently they managed receivables and inventory. The first row presents Intuitive Surgical Inc ’s ROA, ROI, ROE, receivables turnover, and inventory turnover, followed by the corresponding ratios for its peer group, enabling a clear comparison of long-term performance and operational efficiency within corporate Peers.
Methodology & Data Source:
Return on Assets, Return on Investments, Return on Equity, and turnover ratios are calculated using values reported in quarterly and annual financial statements filed with the U.S. Securities and Exchange Commission (SEC). All fundamental data used in these calculations is sourced from CSIMarket.com’s proprietary fundamentals database, which aggregates, standardizes, and normalizes structured XBRL filings across all reporting issuers. Figures may be updated or restated by companies following SEC amendments or revised disclosures.
For a detailed definition of Return on Investments (ROI), see
Return on Investments (ROI).
For Intuitive Surgical Inc ’s historical Return on Assets (ROA) performance, visit
ROA History.
Page last updated:
Data lineage: SEC Filings → XBRL Processing → CSIMarket Database → Growth Calculations.
For broader context and comparisons vs. Peers, visit
CSIMarket’s Company Overview for ISRG Peers .
To download the tables, please subscribe.